Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $2.15 billion. The enterprise value is $2.80 billion.
Important Dates
The last earnings date was Thursday, January 8, 2026, before market open.
| Earnings Date | Jan 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 217.53 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 217.53M |
| Shares Outstanding | 217.53M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 108.76% |
| Float | 205.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 35.47 |
| PS Ratio | 2.43 |
| Forward PS | 2.46 |
| PB Ratio | 1.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 32.43 |
| PEG Ratio | 3.55 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.18 |
| EV / EBITDA | 30.95 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.38.
| Current Ratio | 3.91 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 8.17 |
| Debt / FCF | n/a |
| Interest Coverage | -0.41 |
Financial Efficiency
Return on equity (ROE) is -25.25% and return on invested capital (ROIC) is -0.99%.
| Return on Equity (ROE) | -25.25% |
| Return on Assets (ROA) | -0.46% |
| Return on Invested Capital (ROIC) | -0.99% |
| Return on Capital Employed (ROCE) | -0.85% |
| Revenue Per Employee | $296,005 |
| Profits Per Employee | -$202,669 |
| Employee Count | 2,974 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.63 |
Taxes
| Income Tax | -14.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.62% in the last 52 weeks. The beta is 1.95, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | -14.62% |
| 50-Day Moving Average | 7.08 |
| 200-Day Moving Average | 5.95 |
| Relative Strength Index (RSI) | 76.53 |
| Average Volume (20 Days) | 4,154,768 |
Short Selling Information
The latest short interest is 17.11 million, so 7.86% of the outstanding shares have been sold short.
| Short Interest | 17.11M |
| Short Previous Month | 20.30M |
| Short % of Shares Out | 7.86% |
| Short % of Float | 8.33% |
| Short Ratio (days to cover) | 4.88 |
Income Statement
In the last 12 months, Neogen had revenue of $880.32 million and -$602.74 million in losses. Loss per share was -$2.78.
| Revenue | 880.32M |
| Gross Profit | 404.77M |
| Operating Income | -27.25M |
| Pretax Income | -617.49M |
| Net Income | -602.74M |
| EBITDA | 90.36M |
| EBIT | -27.25M |
| Loss Per Share | -$2.78 |
Full Income StatementBalance Sheet
The company has $145.34 million in cash and $795.07 million in debt, with a net cash position of -$649.73 million or -$2.99 per share.
| Cash & Cash Equivalents | 145.34M |
| Total Debt | 795.07M |
| Net Cash | -649.73M |
| Net Cash Per Share | -$2.99 |
| Equity (Book Value) | 2.10B |
| Book Value Per Share | 9.67 |
| Working Capital | 427.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $66.20 million and capital expenditures -$84.68 million, giving a free cash flow of -$18.47 million.
| Operating Cash Flow | 66.20M |
| Capital Expenditures | -84.68M |
| Free Cash Flow | -18.47M |
| FCF Per Share | -$0.08 |
Full Cash Flow StatementMargins
Gross margin is 45.98%, with operating and profit margins of -3.10% and -68.47%.
| Gross Margin | 45.98% |
| Operating Margin | -3.10% |
| Pretax Margin | -70.14% |
| Profit Margin | -68.47% |
| EBITDA Margin | 10.26% |
| EBIT Margin | -3.10% |
| FCF Margin | n/a |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | -0.23% |
| Earnings Yield | -28.07% |
| FCF Yield | -0.86% |
Dividend DetailsAnalyst Forecast
The average price target for Neogen is $10.67, which is 8.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.67 |
| Price Target Difference | 8.11% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 1.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 0.94 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.94 |
| Piotroski F-Score | 5 |
